Interest in Infusion Therapy Services?

Join Paragon Ventures At NICA 2026

Paragon Ventures team is heading to Las Vegas for the National Infusion Centers Annual Conference. If you are attending stop by our booth and meet our team focused on the infusion therapy services sectors. If you would like to discuss the opportunities in infusion, click here to schedule a private conference with one of our Managing Directors.

WELCOME TO The 2nd Half 2026

H2O - The second half of 2026 is ripe with opportunity.

For healthcare and life sciences business owners, the second half of 2026 presents a compelling window to evaluate and execute strategic options. Buyer demand remains strong, capital is abundant, and high-quality assets continue to be rewarded with premium valuations. Organizations that prepare early, present a clear growth story, and demonstrate operational readiness will be best positioned to maximize value in today's increasingly competitive M&A market.

Key Takeaways for Healthcare & Life Sciences Business Owners

• Buyer demand remains strong across healthcare service and distribution sectors.

• Strategic acquirers and private equity firms continue to have significant capital available

• High-quality businesses with recurring revenue, strong compliance programs, and scalable operations are commanding premium valuations.

• Buyers are placing increased emphasis on financial transparency, quality of earnings, regulatory compliance, and documented growth opportunities.

• Businesses with diversified referral sources, customer concentration controls, and strong management teams are attracting the broadest buyer interest.

• Strong reimbursement relationships, payer contracts, licensing, accreditation, and operational infrastructure remain key value drivers.

• Competitive sale processes continue to generate multiple offers for attractive healthcare and life sciences businesses.

• Business owners should evaluate strategic options before they need to sell, allowing sufficient time to maximize value, address risks, and position the company for a successful transaction.

Contact Paragon Ventures to discover what this means in term of market dynamics and valuation for your healthcare company. We can help you understand where multiples are truly holding up, which models are attracting premium interest from corporate acquirers and strategic private equity. Now is the best time to get ready and prepare to execute for when you decide to grow, partner, or exit, you are negotiating from a position of strength rather than urgency.

For more information, contact the Healthcare M&A Advisory teams at Paragon Ventures.

Considering A Transaction in 2026/2027?

Click here for a Step by Step Overview to Prepare

AVAILABLE FOR ACQUISITION

Paragon Connect Registered Users: Click here to view these and additional acquisition opportunities.

Below are Companies exclusively represented by Paragon Ventures and are subject to prior sale.

Paragon Ventures is pleased to present the following acquisition, merger and recapitalization opportunities for your consideration.

For more information and additional listings please login to our website or click contact the advisory team at Paragon Ventures.

Specialty Durable Medical Equipment Platform

ID # MA323-22014

This well-established company is a national specialty durable medical equipment platform focused on complex products outside the conventional DME model. The company’s core product lines are lymphedema/compression, negative pressure wound therapy (NWPT), neuromodulation, and adjacent specialty categories. The Company is accredited by HQAA and holds multi-State licenses.

The Company’s differentiated operating platform has two complementary channels: a direct to patient specialty DME and a manufacturer facing patient access and reimbursement model. Investment highlights include low inventory, significant payor contracts, purpose-built technology, and operational order flow expertise. 

Financial Performance

FY 2025 the revenue was $28.8M with an adjusted EBITDA of $3.8M. 

Diversified Product Lines

Buyer/Investor Prequalification

Our client engagements require that all interested parties be prequalified before processing an NDA.

SPECIALIZED WORKERS COMP PLATFORM

ID # MA225-12035

Registered Users: Click here for This Listing On-Line

We are currently bringing to market a leading Specialized Pharmacy Distribution Management company focused on serving workers compensation and injured workers in the United States. This well-established pharmacy provides specialized medication services for injured workers under direct and litigated workers’ compensation claims. By handling claims processing, insurance coordination, and direct medication delivery, the company ensures that patients receive the right medication without delays or financial burden.

• Durable, High-Quality Referral Engine - Deep, multi-year relationships with attorneys, physicians, and case managers

• Clean, Predictable Revenue Cycle & Cash Conversion - Proven claims adjudication expertise (especially complex WC rules)

• Scalable Platform with Strong Margins & Compliance - Infrastructure to support growth (technology, fulfillment, reporting)

• Delivering medications: Timely delivery directly to the injured worker's home for quicker access to speed recovery

• Geography: Currently licensed in 17 US States, strategically focused on continued growth and expansion.

About the Company:

• Founded in 2015, this Company has become a regionally recognized specialized pharmacy focused on providing dedicated care through individualized pharmaceuticals for individuals/workers involved in a personal injury.

• This full-service pharmacy platform offers a wide range of services to maximize patient outcomes, including free home deliveries, no out-of-pocket expenses for workers, automated reporting, and a large and growing physician and attorney referral network

Financial Performance:

For the year ended 2025 accrued revenues were ~$11MM generating adjusted EBITDA approaching $5 MM.

This full-service, regulatory compliant pharmacy platform offers a wide range of services to maximize patient outcomes, including free home deliveries, no out-of-pocket expenses for workers, automated reporting, and large, growing physician & attorney referral network

FINANCIAL PERFORMANCE

For the year ended 2025, financial results are expected to produce revenues in the range of $12 -13MM and generating adjusted EBITDA exceeding $ 5MM.

Buyer/Investor Prequalification

Our client engagements require that all interested parties be prequalified before processing an NDA.

Project Garden: Pediatric Nursing & ABA

ID # MA336-10004

Registered Users: Click here for This Listing On-Line

Available for acquisition is a family-owned pediatric nursing and behavioral services group with a 40 year history operating across New Jersey and Delaware. The Company delivers services across three complementary lines — pediatric private duty nursing, applied behavior analysis, and community mental health in home, school and community settings. The business generated $13.5M in net revenue and $1.4M in Adjusted EBITDA for the TTM ending March 31, 2026, with EBITDA margin expanding from 5.3% in 2023 to 10.3% TTM. Experienced non-family management is in place throughout the organization and the owners will support a transition as needed. The group consists of three related entities with shared corporate overhead. 

FINANCIAL PERFORMANCE

The Company generates revenue exceeded $ 7.82MM and EBITDA of $1.13 MM

CARDIOLOGY

Cardiology Practice, Wellness and Advanced Diagnostic Imaging Center

ID # US325-05005

Registered Users: Click here for This Listing On-Line



Cardiology Practice and Imaging Center

Where cutting-edge technology meets compassionate care.

Established cardiology practice with integrated state-of-the-art advanced imaging and diagnostics center. Located in a prime area with a large patient base, the practice is renowned for its comprehensive cardiovascular care and cutting-edge diagnostic capabilities.

Comprehensive Services:

• Full spectrum of cardiology services including diagnostics, imaging (ECHO, Carotid, etc.), treatment, and follow-up.
• Highly advanced sought after imaging modalities including Cardiac PET scanning

State-of-the-Art Facilities:

• Dedicated diagnostic center with the latest equipment and technology.

New procedures and revenue streams:

•  Electrophysiology and Arrhythmia consultations
•  Vein Ablation and Complete Vascular Clinic (procedures/diagnostics)
•   Coronary and Peripheral Angiography and Intervention (stents)
•  Interventional heart valve replacement (TAVR, Mitral Valve, etc)

FINANCIAL PERFORMANCE

• 2025 TTM Sept Revenue $ 3.4 MM - Adjusted EBITDA exceeding $901K
• Diverse payers mix with a significant percentage of insured patients.

Behavioral Health

Behavioral Health Services with Transcranial Magnetic Stimulation Program

ID # US325-05005

Registered Users: Click here for This Listing On-Line



Headquarters in US Northeast region, this behavioral health services provider brings trust and dependability to the community it serves. The company provides educational, social and emotional support through a variety of mental health programs and services. Working with children, teens, adults, couples and families, the Company helps them to reach their full potential in their home, community and society.

Medication Management Anger and Anxiety Grief Counseling Couples Counseling Work and Career Issues LGBTQIA Issues

Children and Adolescents Conflict Resolution Stress Management

TMS Therapy for Depression and Anxiety

Transcranial Magnetic Stimulation Therapy (TMS) is an innovative therapy for those who have moderate to severe depression that have had trouble responding to medication. TMS works by using magnetic fields to increase or reduce specific brain activity. Using TMS allows doctors to change brain activity without surgery and with minimal discomfort to the patient. Deep TMS treatment has been proven to offer significant results by directly stimulating deeper and broader areas of the brain, effectively treating conditions such as depression and anxious depression.

FINANCIAL PERFORMANCE

2024 Revenue $ 4.65 MM - 2025 Revenue $ 5.60 MM

Adjusted EBITDA $600k

Interested in Healthcare M&A Market Activity

Paragon Ventures tracks completed M&A transactions across the continuum of subacute care. If you are considering a sale, merger or acquisition these transactions can provide some benchmarks for your consideration. For more information on the current M&A market for your healthcare business, click here or call 800-719-1555 for more information.

Paragon Ventures Healthcare Market Pulse transactions are provided as a matter of public record. These transactions have been compiled from press releases, corporate announcements and other public sources to provide an overview of acquisition and merger activities within healthcare, medical and life sciences sectors.

We specialize in the confidential sale of healthcare businesses across the continuum of care

With 250+ yrs of healthcare business ownership, operating and M&A experience the Paragon Ventures team understands the intricacies of the sale process. We know how to highlight the Real Value that business buyers demand. From initial strategic exit planning through valuation and marketing to finalizing the sale, Paragon Ventures manages the entire process.

We create business opportunities for people

The merger and acquisition business is a “people business” first and foremost. We understand this. The business owners who have worked with us over the past decade can attest to it.

We create business opportunities that deliver REAL VALUE for real people.

Structuring, negotiating, and closing a deal involves more than mechanics

Our transactions are life-changing for the business owners, their families, and employees. We understand the “psychology of the deal” and the emotions and implications that come with it.

Our confidential process unlocks the REAL VALUE in your company

Understanding your business and its value… presenting the company in its very best light and finding the opportunities that deliver that REAL VALUE.

This is what we do… every day!